In the present study, corticosteroid treatment did not seem to be an interacting factor, since the patients that could potentially have been prescribed corticosteroid treatment for their rheumatic disorder did not have higher levels of cystatin C in their plasma samples. This evidence concerns the gene CST3 and rheumatic disorder.